BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 2672314)

  • 1. [Why are metastases in cirrhotic livers so rare?].
    Seitz G
    Ultraschall Med; 1989 Jun; 10(3):123-6. PubMed ID: 2672314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The importance of lectins for formation of tumor metastases and bacterial infection processes].
    Beuth J; Ko HL; Pichlmaier H; Pulverer G
    Zentralbl Chir; 1993; 118(3):145-52. PubMed ID: 8484288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of cirrhosis on the development of experimental hepatic metastases by B16F1 melanoma cells in C57BL/6 mice.
    Qi K; Qiu H; Sun D; Minuk GY; Lizardo M; Rutherford J; Orr FW
    Hepatology; 2004 Nov; 40(5):1144-50. PubMed ID: 15382152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence study of metastases in cirrhotic livers.
    Pereira-Lima JE; Lichtenfels E; Barbosa FS; Zettler CG; Kulczynski JM
    Hepatogastroenterology; 2003; 50(53):1490-5. PubMed ID: 14571771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and morphology of liver metastasis from extrahepatic malignancies to cirrhotic livers.
    Vanbockrijck M; Klöppel G
    Zentralbl Pathol; 1992 Apr; 138(2):91-6. PubMed ID: 1610770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High metalloproteinase inhibitor content of human cirrhosis and its possible conference of metastasis resistance.
    Barsky SH; Gopalakrishna R
    J Natl Cancer Inst; 1988 Mar; 80(2):102-8. PubMed ID: 2830405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Occurrence of synchronous colorectal cancer metastasis in the cirrhotic or fatty liver].
    Iascone C; Ruperto M; Barillari P
    Minerva Chir; 2005 Jun; 60(3):185-90. PubMed ID: 15985994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stability of real-time MR temperature mapping in healthy and diseased human liver.
    Weidensteiner C; Kerioui N; Quesson B; de Senneville BD; Trillaud H; Moonen CT
    J Magn Reson Imaging; 2004 Apr; 19(4):438-46. PubMed ID: 15065167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelins and their receptors in cirrhotic and neoplastic livers of Canadian and Chinese populations.
    Cai L; Wang GJ; Mukherjee K; Xu ZL; Khalil M; Cherian MG; Chakrabarti S
    Anticancer Res; 1999; 19(3B):2243-7. PubMed ID: 10472337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemical mediators released by primary-cultured human hepatic macrophages in patients with and without cirrhosis: a study in tumor-bearing patients.
    Funaki N; Arii S; Monden K; Higashitsuji H; Furutani M; Mise M; Tanaka J; Imamura M
    Hepatology; 1996 Jun; 23(6):1353-8. PubMed ID: 8675151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence against a role for NADPH oxidase modulating hepatic vascular tone in cirrhosis.
    Gracia-Sancho J; Laviña B; Rodríguez-Vilarrupla A; Brandes RP; Fernández M; Bosch J; García-Pagán JC
    Gastroenterology; 2007 Sep; 133(3):959-66. PubMed ID: 17854599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HGF, MET, and matrix-related proteases in hepatocellular carcinoma, fibrolamellar variant, cirrhotic and normal liver.
    Schoedel KE; Tyner VZ; Kim TH; Michalopoulos GK; Mars WM
    Mod Pathol; 2003 Jan; 16(1):14-21. PubMed ID: 12527708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transforming growth factor-beta 1 (TGF-beta 1) and TGF-beta 1 receptors in normal, cirrhotic, and neoplastic human livers.
    Bedossa P; Peltier E; Terris B; Franco D; Poynard T
    Hepatology; 1995 Mar; 21(3):760-6. PubMed ID: 7875675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of Wilms' tumor suppressor in the liver with cirrhosis: relation to hepatocyte nuclear factor 4 and hepatocellular function.
    Berasain C; Herrero JI; García-Trevijano ER; Avila MA; Esteban JI; Mato JM; Prieto J
    Hepatology; 2003 Jul; 38(1):148-57. PubMed ID: 12829997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylation framework of cell cycle gene inhibitors in cirrhosis and associated hepatocellular carcinoma.
    Roncalli M; Bianchi P; Bruni B; Laghi L; Destro A; Di Gioia S; Gennari L; Tommasini M; Malesci A; Coggi G
    Hepatology; 2002 Aug; 36(2):427-32. PubMed ID: 12143052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Is the sonographic diagnosis of hepatic cirrhosis and hepatic metastases reliable (author's transl)].
    Erckenbrecht J; Waltenberg M; Sonnenberg A; Peter P; Wedershoven HJ; Alfurayh O; Erckenbrecht E; Wienbeck M
    Dtsch Med Wochenschr; 1981 Jul; 106(28):894-7. PubMed ID: 6453711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accumulation of extracellular matrix in the liver induces high metastatic potential of hepatocellular carcinoma to the lung.
    Sawada S; Murakami K; Murata J; Tsukada K; Saiki I
    Int J Oncol; 2001 Jul; 19(1):65-70. PubMed ID: 11408924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lectin binding by liver and lung metastasizing variants of the murine Lewis lung carcinoma.
    Kahn HJ; Brodt P; Baumal R
    Am J Pathol; 1988 Jul; 132(1):180-5. PubMed ID: 3394799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stem-like cells in hepatitis B virus-associated cirrhotic livers and adjacent tissue to hepatocellular carcinomas possess the capacity of tumorigenicity.
    Sun YL; Yin SY; Xie HY; Zhou L; Xue F; Wu LM; Gao F; Zheng SS
    J Gastroenterol Hepatol; 2008 Aug; 23(8 Pt 1):1280-6. PubMed ID: 18466286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and distribution of prolactin receptor in normal, fibrotic, and cirrhotic human liver.
    Simon-Holtorf J; Mönig H; Klomp HJ; Reinecke-Lüthge A; Fölsch UR; Kloehn S
    Exp Clin Endocrinol Diabetes; 2006 Nov; 114(10):584-9. PubMed ID: 17177141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.